The adhesion molecule L-selectin is cleaved rapidly from the surface of activated leukocytes by tumor necrosis factor-␣ converting enzyme, a cell surface metalloprotease, and also undergoes slower constitutive shedding in unactivated cells. The structural features that render it susceptible to shedding are poorly understood. We therefore analyzed the shedding of a series of mutant and chimeric L-selectin molecules. Although murine L-selectin is cleaved at a specific location in the juxtamembrane region 11 amino acids distal to the cell membrane, this cleavage has little sequence specificity. However, proline substitution at the P2 or P3 position or deletion of the epidermal growth factor (EGF) domain completely blocks the rapid phorbol ester-induced cleavage, but does not affect the slower basal proteolytic shedding. Insertion of the 15-residue membrane-proximal region (MPR) of L-selectin into the heterologous protein B7.2 results in a molecule that undergoes constitutive proteolytic turnover. In contrast, insertion of both the EGF domain and the MPR confers susceptibility to both slow constitutive shedding and the rapid proteolytic cleavage induced by phorbol 12-myristate 13-acetate. These results demonstrate that constitutive and induced L-selectin cleavage are separable processes and that the rapid phorbol ester-induced shedding requires the presence of the EGF domain, a sequence that is remote from the cleavage site.
The extracellular domains of many integral membrane glycoproteins undergo proteolytic cleavage and release from the cell surface into the surrounding fluid phase. The biologically significant proteins released in this manner include a number of lymphokines, growth factors, transcription factors, and adhesion molecules (reviewed in Refs. [1] [2] [3] [4] . Proteolytic cleavage is responsible for the regulated secretion of several cytokines derived from transmembrane precursors (5) (6) (7) (8) , and the shedding of surface receptors results in the desensitization of responsiveness to various cytokines (9 -12) . Membrane protein shedding is also implicated in several disease processes. Inherited mutations in the p55 TNF-␣ 1 receptor lessen its sensitivity to proteolysis, cause its decreased proteolytic clearance from the cell surface, and result in a family of inherited autoinflammatory syndromes (13) . Cleavage of the amyloid precursor protein (APP) at the ␤ and ␥ sites, releasing the amyloidogenic A␤ fragment, is implicated in the pathogenesis of Alzheimer's disease, and mutations that increase secretion of this peptide are associated with familial Alzheimer's disease (14 -16) . The enzymes responsible for such cleavage are collectively referred to as membrane secretases or sheddases. A common mechanism for the secretion of many of these proteins has been inferred from the ability to inhibit their release with new hydroxamic acid-derived metalloprotease inhibitors (17) (18) (19) (20) (21) and by the identification of a mutant cell line that is defective in cleaving multiple proteins (22) . More recently, a plasma membrane enzyme responsible for the shedding of TNF-␣, the TNF-␣ converting enzyme (TACE) (23, 24) , a member of the ADAM (a disintegrin and metalloprotease) family (25) , was also shown to cleave TGF-␣, TNF-␣ receptor types I and II (26, 27) , Notch1 (28) , the receptors for IL-6 and CSF-1 (29, 30) , and APP (31) . Genetic deficiency of TACE is embryonically lethal, demonstrating the importance of TACE-mediated shedding in vivo (26) . L-selectin (CD62L) is a leukocyte transmembrane glycoprotein that mediates the initial adhesive interaction of lymphocytes to specialized vascular endothelial cells in lymph node high endothelial venules and of leukocytes to endothelium at sites of inflammation. In addition to being required for the homing of lymphocytes to lymph nodes (33) , L-selectin may transduce co-stimulatory signals for cell activation and for the up-regulation of integrin adhesiveness necessary for the transition from rolling to firm adhesion (34 -40) . The expression of L-selectin is differentially regulated by resting and activated lymphocytes at the transcriptional, mRNA, and post-translational levels (41, 42) . In resting cells, L-selectin undergoes relatively slow, constitutive shedding. Stimulation by PMA or, for T cells, through the T cell receptor, induces the rapid upregulation of shedding, releasing the soluble, ligand-binding ectodomain fragment into the supernatant and removing most of the protein from the cell surface within a few minutes (42, 43) . Human neutrophils similarly shed L-selectin after treatment with chemotactic agents, phorbol esters, lipopolysaccharide, or calmodulin antagonists (44, 45) . The presence of the soluble L-selectin fragment in normal serum indicates that this proteolytic shedding process also takes place in vivo (46) . Lselectin shedding regulates the rolling velocity of loosely adherent leukocytes along the endothelium, an early step in leukocyte-endothelial interaction (47, 48) . We have suggested that L-selectin cleavage may be required for de-adhesion during the transendothelial migration of lymphocytes through the high endothelial venule vessel wall and into the lymph node parenchyma (49) , a proposal supported by the observation that lymphocytes down-regulate L-selectin during migration through high endothelial monolayers in vitro (50) .
The phorbol ester-induced proteolytic shedding of L-selectin is mediated by the same enzyme, TACE, that processes pro-TNF-␣ and is blocked by inhibitors of zinc-dependent metalloproteases (26, (51) (52) (53) . TACE cleaves both human and mouse L-selectin at homologous sites just external to the cell membrane ( Fig. 1) , releasing the majority of the protein into the supernatant and leaving a membrane-retained fragment (MRF) consisting of the cytoplasmic and transmembrane domains and the first 11 amino acids of the extracellular juxtamembrane region (54, 55) . Metalloproteolytic shedding of most proteins shows little specificity for the sequence around the cleavage site, and the structural features that determine transmembrane protein susceptibility to shedding are therefore poorly understood. One general feature of protease recognition is that the cleavage is positioned primarily with respect to the proximal extracellular globular domain, requiring only a susceptible membrane-proximal stalk of sufficient length to permit access of the protease to the substrate (1, 3) . Indeed, it has even been proposed that membrane secretases will cleave any surface protein that lacks a bulky globular domain close to the cell surface (4) . The shedding of human L-selectin is relatively sequence-nonspecific, and other determinants of protease recognition of membrane L-selectin have not been defined (54, 56, 57) .
In the present studies, we analyzed the regulation of proteolytic shedding in transfectants expressing a series of point and domain swap mutants of murine L-selectin. Although shedding is not blocked by most point mutations in the membraneproximal region, some mutations and deletions completely block PMA-induced proteolysis. Surprisingly, however, these mutant molecules still undergo the constitutive metalloproteolytic shedding that is characteristic of unactivated cells, demonstrating that these two processes are inherently separable and may be mediated by different enzymes. Furthermore, while the short juxtamembrane region of L-selectin is sufficient to confer susceptibility to this basal cleavage, the EGF domain is required for rapid phorbol ester-induced shedding. The EGF domain therefore likely serves as a recognition motif for the phorbol ester-stimulated protease, enhancing its interaction with substrate and increasing the rate of proteolytic cleavage.
EXPERIMENTAL PROCEDURES
Cell Culture and Monoclonal Antibodies-An L-selectin-negative subclone of the mouse T lymphoma cell line TK-1 was maintained in RPMI 1640 supplemented with 10% fetal calf serum, penicillin, streptomycin, glutamine (20 mM), HEPES, and ␤-mercaptoethanol (50 mM). The stable transfectant lines were maintained in the complete medium containing 0.5 mg/ml G418 (Calbiochem). The following antibodies were used in this study: MEL-14: rat IgG2a, anti-mouse L-selectin (33); T28: mouse IgG2b, anti-mouse L-selectin of the Ly22 ϩ allotype (58); GL-1: rat IgG2a, anti-mouse B7.2 (59) . mAbs were isolated from tissue culture supernatants and conjugated to biotin or phycoerythrin (PE) in this laboratory or were used unpurified in two-stage staining (for GL-1). PE-labeled streptavidin and PE-conjugated goat-anti-rat Ig antibody were purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL).
Immunofluorescence and Flow Cytometry-Five ϫ 10 5 cells were resuspended in 0.5 ml of Hanks' balanced salt solution containing 10% horse serum (FACS buffer) in test tubes. For testing PMA-induced shedding, the cells were incubated with 100 ng/ml PMA at 37°C for the times indicated, followed by staining with PE-conjugated MEL-14 for L-selectin expression, or with GL-1 followed by PE-conjugated goatanti-rat Ig for B7.2 expression. For testing the effect of a metalloprotease inhibitor on PMA-induced shedding of L-selectin mutants or chimeric molecules, the cells were preincubated with 50 M Ro 31-9790 (51) at room temperature for 20 min. Then, PMA was added at 100 ng/ml and the cells were further incubated at 37°C for 30 min, followed by staining as described above. For all experiments, cells treated with the same concentration of Me 2 SO as the experimental tubes were used as a control. To determine the Ly22 allotype of the L-selectin expressed in the transfectants, cells were stained with biotin-conjugated T28 followed by PE-labeled streptavidin. Cells stained with normal Ig were used as negative controls. All immunofluorescence was analyzed on a FACS Vantage (Becton-Dickinson, San Jose, CA).
Anti-L-selectin Cytoplasmic Domain Peptide Antibodies-A peptide corresponding to the cytoplasmic domain of mouse L-selectin (NH 2 -RRLKKGKKSQERMDDPY-COOH) conjugated to diphtheria toxoid (Chiron Mimotopes, Clayton, Victoria, Australia) was used to immunize rabbits. Specific antibody was then purified by passing the resulting antisera over a column containing the cytoplasmic domain peptide bound to Sepharose CL-4B (Amersham Pharmacia Biotech) and eluting it at low pH. The purified antibodies were conjugated to Sepharose beads and used for immunoprecipitation. To confirm the specificity of the anti-cytoplasmic peptide antibody, normal spleen cell lysates were immunoprecipitated with MEL-14 or the polyclonal antibody and then analyzed by Western blot as described below. Both the monoclonal MEL-14 and polyclonal rabbit antibody precipitated protein with the mobility of murine lymphocyte L-selectin. In cross-clearing experiments, precipitating cell lysates with MEL-14 removed all such material precipitable with the polyclonal serum and vice versa (data not shown). Furthermore, PMA treatment results in the down-regulation of membrane protein detectable with both antibodies, as shown in several of the figures herein.
cDNA Constructs-Site-specific mutations, domain deletions, domain swap, and chimeric molecules were generated using a sequential PCR method. Ala 184 (GCA) in the cDNAs of wild-type and all L-selectin mutants was changed to Glu (GAA) to mark them with the Ly22 Ϫ allotype. The DNA sequence encoding the MPR of L-selectin was inserted between the transmembrane domain and extracellular domain of B7.2 to generate the cDNA of B7.2/MPR. Then, a HindIII site (AAGCTT) was introduced into the B7.2/MPR cDNA between the sequence of the MPR and B7.2 extracellular domain. The DNA fragments encoding the EGF domain, SCR domain, or EGF plus one SCR domain of L-selectin, with flanking HindIII sites, were amplified from wild-type L-selectin cDNA. These amplified DNA fragments were cloned into B7.2/MPR cDNAs using the introduced HindIII site to generate the chimeras B7.2/MPR/EGF, B7.2/MPR/SCR, and B7.2/MPR/EGFϩSCR. Wild-type L-selectin, all L-selectin mutants, and the chimeric cDNAs were inserted into the pHSE vector, kindly provided by Dr. D. Raulet (60) . The sequences of all of these mutants were verified by sequencing.
Stable Transfection-The cDNAs encoding the wild-type L-selectin, L-selectin mutants, and the B7.2 chimeric molecules in the pHSE vector were used to cotransfect L-selectin-negative TK-1 cells with pCDNA3. After electroporation, the cells were selected in complete medium containing 2 mg/ml G418. Ten to 20 clones from each transfection were tested by flow cytometry after staining with PE-conjugated MEL-14 for L-selectin, or GL-1 for B7. , and cytoplasmic domain (Cy). The MPR is enlarged to show the amino acid sequence of this region from mouse, rat, and human Lselectin and mouse P-and E-selectin. Amino acid positions for the mature mouse L-selectin are indicated below the sequence, and the cleavage site is indicated (छ). The sequence of the MPR of L-selectin is evolutionarily highly conserved, but has no homology with the shorter MPRs of the other members of the selectin family, E-and P-selectin.
itive for MEL-14 staining were confirmed to be Ly22-negative by staining the cells with T28. At least three clones of each transfectant with positive staining for MEL-14 or GL-1, but negative for T28, were used in these studies. Since the EGF domain deletion mutant (⌬EGF) cannot be recognized by either MEL-14 or T28, its expression was detected by Western blot analysis using the polyclonal antibody specific for the cytoplasmic domain of L-selectin. Plasma membrane expression of this mutant L-selectin was confirmed by its ability to be surface-labeled with 125 I, and its smaller size distinguished it from endogenous wildtype L-selectin, as shown under "Results."
Western Blot Analysis-Untreated or PMA (100 ng/ml)-stimulated normal lymphocytes or transfectants were lysed, precleared with nonimmune rabbit IgG-Sepharose beads, and immunoprecipitated with Sepharose beads coupled to the rabbit anti-L-selectin cytoplasmic domain antibody. Eluates were separated on 10 -20% Tricine-SDS gradient gels (Novex, San Diego, CA), transferred to Protran nitrocellulose membranes (Schleicher and Schuell), and then probed with the polyclonal anti-cytoplasmic domain peptide antibody followed by chemiluminescence detection with LumiGLO Substrate (Kirkegaard and Perry Laboratories, Gaithersburg, Maryland) and Kodak BioMax Light-1 film (Eastman Kodak Co.). I-labeled cells were left untreated or were treated with 100 ng/ml PMA, with or without pretreatment with Ro 31-9790 for 20 min. Cells incubated in the same concentration of Me 2 SO (0.1%) were used as a negative control. After the various treatments, the cells were lysed. Lysates and supernatants were precleared with Sepharose conjugated to irrelevant rat IgG2a antibody and then immunoprecipitated with protein G beads precoated with MEL-14 or, for B7.2 chimeras, with GL-1 antibody. Eluates from these beads were then resolved by 8 or 10% SDS-PAGE under reducing conditions. To remove N-linked oligosaccharides from the immunoprecipitated proteins, the antigens were eluted by boiling the beads in incubation buffer (20 mM sodium phosphate, pH 7.5, 50 mM EDTA, 0.02% sodium azide) containing 0.5% SDS and 5% ␤-mercaptoethanol and digested with N-glycanase (Oxford GlycoSciences, Wakefield, MA). Labeled proteins were detected by exposing dried gels to Kodak X-Omat AR-5 film at Ϫ70°C.
RESULTS

Rapid PMA-induced Shedding of L-selectin from Normal
Murine Lymphocytes-Treatment with phorbol esters that activate protein kinase C causes rapid L-selectin shedding from the surface of normal lymphocytes (43) . As illustrated in Fig.  2A , L-selectin expression on normal lymphocytes, detected by flow cytometric analysis using the mAb MEL-14, decreases rapidly after PMA treatment, with about 90% loss in 30 min. This down-regulation is not affected by treatment with inhibitors of serine and several other proteases (43) . 2 However, pretreatment of the cells with Ro 31-9790, a zinc-dependent metalloprotease inhibitor, blocks this down-regulation, suggesting that it is mediated by a metalloproteolytic secretase. To confirm that the down-regulation of L-selectin was due to a proteolytic mechanism, PMA-treated and untreated cells were immunoprecipitated with polyclonal antibody specific for the cytoplasmic domain of L-selectin and then examined by Western blot analysis, probing the membrane with the same polyclonal antibody (Fig. 2B) . In untreated normal lymphocytes, there is a broad 95-kDa band corresponding to intact L-selectin. In addition, there is a 6-kDa band that represents the protein fragment remaining in the membrane after L-selectin shedding. The presence of this MRF in the lysates of untreated cells shows that L-selectin undergoes base-line constitutive shedding in the absence of PMA, as we have demonstrated previously (43) . After PMA treatment, the 95-kDa band decreases in intensity, as expected, while that of the MRF increases at 5, 10, and 15 min after PMA treatment, reflecting its generation during proteolytic cleavage. Then, the intensity of the MRF band decreases as the fragments are gradually cleared from the cell surface. These data show that, upon PMA stimulation, L-selectin in normal murine lymphocytes is proteolytically cleaved and shed by a membrane metalloprotease in a process similar to that shown in human cell lines (54) . Based upon the mobility of the MRF bands, the proteolytic cleavage site appears to be the same for both the slow basal cleavage and the rapid PMA-stimulated shedding.
Expression of Mouse L-selectin Mutants in the TK-1 Cell Line-To determine the structural properties of L-selectin required for its shedding, we analyzed its expression in the murine lymphoma cell line TK-1 transfected with cDNAs encoding wild-type and mutant L-selectin. As was observed with normal lymphocytes, the expression of wild-type L-selectin transfectants decreased markedly after 30-min treatment with PMA (Fig. 3A) . This down-regulation was completely inhibited by the metalloprotease inhibitor Ro 31-9790. Western blot analysis of the wild-type L-selectin transfectant shows the same size in- tact L-selectin (95 kDa) and MRF (6 kDa) as those of normal lymphocytes (Fig. 3B) . These results show that the shedding of L-selectin in TK-1 cells stably transfected with wild-type Lselectin occurs in a manner identical to that in normal murine lymphocytes. TK-1 transfectants were therefore used for the following L-selectin structure/function analyses. Western blots with the anti-cytoplasmic domain antibody were used to detect the full-length mature protein and the membrane-retained fragment. In complementary experiments, cell surface iodination was used to demonstrate 1) whether a protein detected by Western blot, which cannot differentiate between cell surface and cytoplasmic protein, is actually expressed on the cell surface, and 2) to determine whether a mutant protein is constitutively cleaved and released into the supernatant.
Inhibition of Both Constitutive and PMA-induced Shedding of L-selectin by a Metalloprotease
Inhibitor-To examine the processes of PMA-induced and constitutive shedding of L-selectin, cell surface proteins on the wild-type L-selectin transfectant were labeled with 125 I and then incubated further in the presence or absence of PMA. L-selectin was then immunoprecipitated from the cell surface and supernatant with anti-Lselectin mAb and analyzed by gel electrophoresis. As shown in Fig. 4 , broad 95-kDa bands, corresponding to the intact cell surface molecule, are detected in lysates of unactivated cells at time 0 or after 30-min incubation in the absence of PMA. Stimulation of cells for 30 min with phorbol ester results in a 94% decrease in the intensity of the lysate band (lane 5), similar to the decrease observed by flow cytometry, and the appearance of a slightly more mobile band in the supernatant, corresponding to the shed ectodomain (lane 6). The basal shedding of L-selectin is relatively slow; after 60-min incubation without PMA, only 12% of the surface L-selectin has been shed into the supernatant fraction (lane 10). When transfectants were pretreated with the metalloprotease inhibitor Ro 31-9790, both the PMA-induced and constitutive shedding of 125 I-labeled L-selectin was markedly inhibited; only 5% and Ͻ1% of the starting membrane antigen appeared in the supernatants of activated and resting cells, respectively. These data show that phorbol ester stimulation induces the rapid up-regulation of L-selectin shedding and that both the slow basal shedding and the more rapid PMA-induced shedding are mediated by the same, or similar, metalloproteolytic mechanisms.
Conservation of the Primary Sequence around the Cleavage Site Is Not Required for PMA-induced Shedding of Murine
L-selectin-To determine the specificity of murine L-selectin cleavage, point mutations within the MPR of mouse L-selectin were analyzed for their effects on shedding. The expression of wild-type L-selectin and its mutants before and after PMA stimulation was determined by flow cytometric analysis using MEL-14 mAb, and shedding of L-selectin molecules was evaluated as the percentage decrease of L-selectin expression after PMA treatment, as summarized in Fig. 5 . L-selectin mutants with both conserved (R321K, S322T) and nonconserved (N320A, R321I, R321A, S322I, F323A) point mutations of the P1, P2, P1Ј, and P2Ј positions shed well (Ͼ70%) after PMA stimulation. A molecule with alanine substitutions of residues 329 -332 also sheds in response to PMA. Shedding by all of the L-selectin mutants was inhibited by the metalloprotease inhibitor, and Western blots of the representative mutants R321I, F323A, and S322I showed 6-kDa MRF bands (data not shown), indicating that their shedding is mediated by the same proteolytic mechanism as for wild-type L-selectin. Thus, shedding of the murine L-selectin molecule has little specificity for the amino acid sequence at the substrate cleavage site.
Different Structural Requirements for Constitutive and PMAinduced Shedding-In contrast to the down-regulation of most L-selectin point mutants, proline substitution mutations at the P2Ј and P3Ј positions (F323P and S324P), which could markedly change the secondary structure of the MPR, completely block shedding induced by PMA (Figs. 5 and 6A ). Western blot analysis of the F323P transfectant revealed the expected 95-kDa band, but, surprisingly, also showed a strong band identical to the 6-kDa MRF of the wild-type and other mutants (data not shown). Neither of the bands in F323P is affected by PMA treatment. Since this fragment arises only after the proteolytic cleavage of L-selectin, the following experiment was carried out to examine directly whether the F323P protein undergoes shedding from the cell surface. F323P transfectant cells were labeled with 125 I, washed, treated with PMA, and the cell lysates and supernatants were then immunoprecipitated with MEL-14. As shown in Fig. 6B , soluble ectodomain was released into the supernatant of unstimulated cells, and the amount shed did not increase with the addition of PMA. After (1, 3, 56, 57) . To determine whether murine L-selectin is similarly affected by the MPR length, eight amino acids in the membrane-proximal region (Lys 325 to Asn 332 ) were deleted. This mutant protein (⌬K-N) was expressed at high levels and was completely resistant to PMAinduced down-regulation (Fig. 7A) . To determine whether the ⌬K-N deletion mutant undergoes constitutive shedding, transfectant cells were labeled with 125 I and then incubated for 3 h in the absence of PMA. As shown in Fig. 7B , 69% of the wild-type L-selectin appears in the supernatant after 3 h in vitro. In contrast, less than 2% of the ⌬K-N molecules were released into the supernatant, and the lysate contained virtually all of the mutant L-selectin that was present at time 0. Thus, truncation of the membrane-proximal region abolishes both constitutive and PMA-induced release of L-selectin, even though the cleavage site sequence is intact. These results suggest that a minimal MPR length of at least eight amino acids is required for the cleavage of cell surface Lselectin, both the slow constitutive shedding and the rapid shedding induced by PMA.
The Roles of the EGF, SCR, Transmembrane, and Cytoplasmic Domains in L-selectin Shedding-Domains other than the juxtamembrane region could be important for recognition of L-selectin by TACE. To identify potential sites of interaction with the protease, a series of domain deletion and domain swap mutants were generated as shown in Fig. 8A . The expression of these L-selectin mutants was determined by flow cytometric analysis, except the ⌬EGF deletion mutant. This molecule was detected in Western blots using the anti-L-selectin cytoplasmic domain antibody. The shedding by these L-selectin mutants is inhibited by the metalloprotease inhibitor (data not shown).
The sequence of the transmembrane domain of L-selectin is highly conserved throughout evolution (56), suggesting that it may have some role other than membrane anchoring. Intermolecular recognition can occur within the plane of the membrane, and some membrane secretases cleave their substrate proteins within the transmembrane domains (4). However, replacing the transmembrane domain of L-selectin with that of P-selectin, which shares no sequence homology (Fig. 1) , had little effect on PMA-induced shedding (Fig. 8A) . Other work has suggested a role for the cytoplasmic domain in the regulation of L-selectin cleavage (57) and in lymphocyte adhesion I were incubated without stimulation at 37°C for 3 h. The cell lysates (L) and supernatants (S) were analyzed as described in the legend to Fig. 4. (62). We therefore examined the shedding of L-selectin in which part or all of its cytoplasmic tail had been deleted. An L-selectin mutant lacking the last 11 amino acids of its cytoplasmic domain (⌬CYp), which removes the potential protein kinase C phosphorylation site, is shed as efficiently as wildtype L-selectin (Fig. 8A) . Further deletion of the five amino acids adjacent to the membrane (⌬CYc) moderately decreases, but does not block, PMA-induced shedding.
EGF domains are found in many proteins, including other proteins that are proteolytically shed (63) . In addition, SCRlike regions in several proteins have been implicated in the regulation of protease activity (64) . Thus, the EGF and SCR regions of L-selectin are candidate domains that might mediate contact with the protease and enhance cleavage. The corresponding deletion mutants were therefore examined for shedding. Western blot analysis of the ⌬EGF and ⌬SCR mutants showed bands corresponding to the uncleaved membrane forms of L-selectin that are smaller than that of wild-type L-selectin, as expected from their shorter sequences (Fig. 8B) . The ⌬EGF L-selectin mutant is expressed at a high level by TK-1, but its expression does not decrease in response to PMA (Fig. 8B) . Despite this resistance to PMA-induced cleavage, a 6-kDa MRF band is precipitated from lysates of both PMA-treated and untreated cells, indicating that this molecule undergoes constitutive shedding. Deletion of the two SCR domains resulted in a molecule that sheds moderately in response to PMA, with a 44% decrease in the intensity of the band corresponding to the intact surface molecule (Fig. 8B) . Lysates of ⌬SCR also contain a very strong MRF band, regardless of whether they had been activated by PMA or left untreated, suggesting that there is a high rate of constitutive shedding and selectin turnover in these cells.
The EGF mutant was examined further to determine whether it is indeed expressed on, and shed from, the cell surface, using surface labeling and precipitation with the polyclonal anti-cytoplasmic domain antibody. As shown in Fig. 8C , bands corresponding to the full-length surface molecule were obtained from lysates of both resting and PMA-activated cells. Furthermore, there was no decrease in band intensity after PMA treatment, confirming that this construct is completely insensitive to PMA-induced proteolytic cleavage, as suggested by the Western blot experiments.
The Membrane-proximal Region of L-selectin by Itself Can Fully Confer Constitutive Shedding upon an Unrelated Surface
Protein-Since only the 8-amino acid deletion in the MPR of L-selectin (⌬K-N) is sufficient to block all constitutive shedding, and neither the EGF or SCR domains affect this basal cleavage, it is possible that the 15-amino acid MPR sequence is sufficient to mediate constitutive shedding from the cell surface, but not the rapid, inducible shedding. To test this hypothesis, a chimeric cDNA (B7.2/MPR) was constructed in which the MPR of L-selectin was inserted into the membrane-proximal sequence of murine B7.2, which has no sequence homology to L-selectin. As shown in Fig. 9A , treatment with PMA for 30 min does not induce any decrease of wild-type B7.2 expression, and only slight (11%, mean of six experiments) down-regulation of B7.2/MPR was observed. Thus, the MPR of L-selectin can confer at most a very low level of PMA-induced shedding upon the surface protein B7.2. Interestingly, when cells are incubated for 3 h in the presence of the metalloprotease inhibitor in the absence of PMA stimulation, the expression of the chimeric molecule, but not wild-type B7.2, increases by 1.5-fold (Fig. 9B) , consistent with blocking basal proteolytic shedding.
To determine whether the B7.2/MPR chimeric molecule undergoes constitutive cleavage, transfectants were surface-labeled with 125 I, incubated in the absence of stimulation, and the lysates and supernatants immunoprecipitated using anti-B7.2 antibody. As shown in Fig. 9C (left panel) , 83% of the labeled B7.2/MPR was released into the supernatant (mean of two experiments) after 3-h incubation in the absence of stimulation, similar to the 69% constitutive shedding of wild-type L-selectin (Fig. 7B ). It has previously been shown that electrophoretic estimation of the relative molecular weights of intact amphipathic membrane glycoproteins and shed fragments is inaccurate unless the proteins are first deglycosylated (1, 43) . Thus, to assess more precisely the size difference between the surface protein and the shed fragment, both the cell lysate and supernatant-derived eluates were N-deglycosylated before electrophoretic analysis. Bands from enzymatically deglycosylated proteins demonstrate the small 1.5-kDa difference between membrane B7.2 and B7.2/MPR (Fig. 9C, right panel) . The apparent molecular mass of the shed B7.2/MPR fragment is 8.5 kDa smaller than the cell surface form, indicating that The EGF Domain of L-selectin Is Sufficient for Rapid (Induced) Proteolysis of MPR-containing Proteins-The above data showed that an intact MPR is necessary for shedding and that the EGF domain is required for optimal PMA-induced rapid proteolytic cleavage of L-selectin. We next addressed the question of whether the EGF domain by itself is sufficient to render an MPR-containing protein susceptible to PMA-induced shedding. A series of chimeric molecules were generated based on the B7.2/MPR molecule, as illustrated in Fig. 10A . PMA induced 64% down-regulation of expression of the chimeric molecule containing the EGF domain adjacent to the MPR (B7.2/MPR/EGF; Fig. 10B) . Pretreatment of the transfectant with the metalloprotease inhibitor completely blocked this decrease. In contrast to the dramatic effect of the EGF domain, insertion of an SCR domain into B7.2/MPR (B7.2/MPR/SCR) resulted in little change in PMA-induced proteolysis (mean down-regulation ϭ 18% versus 11% for B7.2/MPR). A transfectant expressing the chimeric molecule containing both the EGF and SCR domains (B7.2/MPR/EGFϩSCR) sheds 74% from the surface in response to PMA. To confirm these results, electrophoretic analysis was performed on 125 I-labeled cells (Fig.  10C) . In unstimulated B7.2/MPR/SCR transfectants, 6% of the cell surface chimera appeared in the supernatant after 30 min. Treatment with PMA increased this to 22%, with a corresponding reduction in the intensity of the cell surface (lysate)-derived band. This net increase (16%) in shedding correlates well with the small amount of down-regulation observed by flow cytometry. A comparable proportion of labeled B7.2/MPR/EGF (10%) was spontaneously released into the supernatant in 30 min. In contrast to the SCR-containing chimera, however, 91% of the B7.2/MPR/EGF protein was shed in response to PMA, again demonstrating the importance of the EGF domain in the proteolytic process.
DISCUSSION
Numerous membrane proteins are proteolytically cleaved and shed from the surface of leukocytes and other cell types (1, 3) . Some of these proteins, such the mannose receptor, are shed constitutively and the rate of shedding is unaffected by cell activation (65) . The cleavage of other proteins is induced or accelerated by cell activation, and it has been estimated that up to 4% of cell surface protein is shed after phorbol ester stimulation (22) . Many of these proteins are cleaved by metalloproteolytic enzymes that are members of the ADAM family, although other classes of proteases are responsible for the shedding of some proteins (1). TNF-␣ is constitutively shed at a high rate, almost completely removing the cytokine from the cell surface. This cleavage, mediated by TACE, is accelerated moderately by phorbol esters (66) . In contrast, murine lymphocyte L-selectin undergoes relatively slow basal shedding from unactivated cells, and its rate of proteolytic release increases dramatically after activation by PMA or anti-CD3 mAb (42, 43) . This rapid release is mediated by TACE (26) and is blocked by metalloprotease inhibitors (Fig. 2A ). In the current study, we have demonstrated that the slow constitutive shedding and rapid inducible shedding of L-selectin are separable processes with distinct structural requirements and that optimal shedding of L-selectin depends upon sequences remote from the proteolytic cleavage site in the EGF domain.
Even though many integral membrane proteins are processed by plasma membrane secretases, it is clear that most proteins are not cleaved from the cell surface and therefore that components of the proteolytic process must recognize structural features of the relevant substrates. The structural features of substrate proteins required for cleavage are incompletely understood. One characteristic common to membrane metalloproteolytic secretases is that they have relatively low specificity for the amino acid sequence of the substrate (1, 3) . Most mutations introduced into the MPR of murine (Fig. 5) and human (56, 57) L-selectin do not block proteolytic cleavage. Similarly, most amino acid substitutions in the juxtamembrane region of TGF-␣ (67), TNF-␣ (7), and APP (68) do not inhibit their proteolysis. However, introduction of a proline into this region of L-selectin, which would be expected to disrupt its secondary structure, markedly inhibits its cleavage (Fig. 6) , as it does for APP and the p55 and p75 TNF-␣ receptors (69 -71) . Thus, at least some overall structure of this substrate region must be maintained for protease recognition. The inherent substrate activity of the MPR of L-selectin was demonstrated by its ability to confer constitutive shedding upon the unrelated transmembrane glycoprotein B7.2 (Fig. 9) . The juxtamembrane regions of several other shed proteins, including APP, TGF-␣, and the TNF-␣ receptor I, are also sufficient to mediate shedding when inserted into heterologous membrane proteins (70, 72) . In an examination of the cleavage of synthetic substrate oligopeptides by purified TACE, it was shown that cleavage of the TNF-␣ peptide was 2250 times more efficient than that of L-selectin (26) . This strong interaction between the processing enzyme and the juxtamembrane region of TNF-␣ may explain why TNF-␣ undergoes so much more rapid constitutive shedding than does L-selectin.
One structural feature generally required for the cleavage of membrane metalloprotease substrates is that they have a stalk region of a minimal length between the plasma membrane and the first globular ectodomain (1, 3 ). This appears to be necessary for the proteolytic enzyme to gain access to the substrate's cleavage site. Juxtamembrane amino acid deletions block cleavage of several proteins, regardless of whether the sequence at the cleavage site remains intact, if the remaining stalk is shorter than a minimal length, generally about 10 -12 amino acids. A 19-residue deletion in the membrane-proximal region of APP, which includes the cleavage site, results in a new cleavage site 12 amino acids external to the transmembrane domain, the same distance from the membrane as with wild-type APP (68) . Only 11 of the original 35 amino acids of the APP juxtamembrane region are required for proteolytic processing to occur. Similar results found with TNF-␣ and the p75 TNF-␣ receptor have confirmed the general principle that the shedding enzyme requires a certain stalk length for access and that it positions itself for cleavage primarily with respect to the plasma membrane and the proximal extracellular domain (1). This distance from membrane requirement may pertain only to metalloproteases, as the aspartyl protease responsible for the ␤-secretase processing of APP cleaves only with respect to a strict amino acid sequence specificity (73) . The lack of PMA-induced down-regulation of the L-selectin ⌬K-N deletion mutant is in keeping with the requirement for a minimal MPR length for proteolytic cleavage by TACE.
Examination of domain deletion mutants and chimeras revealed additional structural information about the regulation of L-selectin shedding. Deletion of the EGF domain resulted in a molecule (⌬EGF) that does not down-regulate in response to PMA (Fig. 8) . Conversely, when the EGF domain was inserted into B7.2/MPR, which undergoes primarily constitutive shedding, it became susceptible to PMA-induced rapid cleavage (Fig. 10 ). These experiments demonstrate that the EGF domain of L-selectin, while not required for its basal proteolytic turnover, is necessary for optimal PMA-induced rapid cleavage. In contrast to the EGF domain, insertion of the SCR regions into B7.2/MPR resulted in a molecule (B7.2/MPR/SCR) in which the PMA-induced shedding was increased by only 16%. Thus, the SCR domains of L-selectin are not essential for either basal or stimulated shedding.
EGF domains frequently mediate protein-protein interactions and are present in other membrane proteins that are shed, including TGF-␣ (74), EGF (8), heparin-binding EGF-like growth factor (75) , and Notch1 (76) . This is consistent with our previous suggestion that the EGF domain of membrane-bound L-selectin contains a docking site for the protease (49) . This would be analogous to the membrane-distal region of angiotensin-converting enzyme that contains a recognition motif that is required for its cleavage by a membrane secretase (77) . Solution of the crystal structure of TACE has revealed several large insertion loops that extend out from the surface of the catalytic domain, but separate from the active site, and that have been postulated to be sites of interaction with substrate (3, 78) . TACE is thought to interact with a docking site in the base of the compact cone region of TNF-␣, a site distant from that of its scissile bond in the juxtamembrane stalk (78) . The binding of TACE to an analogous docking site on L-selectin would have an even more dramatic effect on cleavage of L-selectin than of TNF-␣ because of the much lower apparent affinity of interaction of the MPR of L-selectin for the protease. Thus, when the EGF domain of L-selectin binds to TACE, the overall avidity of interaction with substrate would be enhanced, and the shedding rate would increase correspondingly.
Another potential site of substrate interaction with the enzyme is within the transmembrane region of L-selectin, similar to the interactions of proteins with ␥-secretases. However, the transmembrane domain substitution chimeric molecule sheds well in response to PMA, demonstrating that the transmembrane region is not involved in protease recognition. Similarly, since the B7.2/MPR/EGF chimeric protein undergoes rapid shedding, the lectin domain of L-selectin is not required for its proteolytic release.
The nature of the signals and structural changes that lead to activation of the rapid shedding process are poorly understood. Several lines of evidence have led to the general belief that the sheddase exists in the membrane in a constitutively active state and that the induction of shedding therefore involves a change in the substrate to a conformation more susceptible to proteolysis. Thus, TACE continuously cleaves pro-TNF-␣ at a high rate in unstimulated cells. Purified TACE also cleaves some substrate peptides and proteins in the soluble phase (23, 24, 26) . In addition, a point mutation in the MPR of human L-selectin (K283A) causes this molecule to be shed continuously from untreated cells (56). We propose that the activation of L-selectin to a protease-sensitive conformation exposes a cryptic contact site within the EGF domain and thereby facilitates its interaction with TACE, as described above. The in-ability of proline substitution mutants to undergo PMA-induced shedding would then result from their inability to adopt the conformation necessary for the docking of the EGF domain to TACE, while still permitting the slower MPR-mediated constitutive cleavage. It is possible that a conformational change may also occur in the MPR under activating conditions and that the proline substitution mutations prevent this. This would be consistent with the small PMA inducibility of shedding of the B7.2/MPR chimera. Since the cytoplasmic tail of L-selectin is not required for the activation (or inhibition) of proteolytic processing, the transition of L-selectin to the more proteolytically susceptible conformation could arise from the PMA-induced interaction with the extracellular domain of a separate regulatory membrane protein. The recent demonstration that perturbation of surface thiol groups induces shedding suggests that a membrane protein sulfide isomerase could be such a regulatory protein (80) .
The distinct structural requirements for basal and stimulated shedding suggest that these activities may be mediated by different secretases, with only the enzyme mediating activation-dependent shedding (TACE) being blocked by the proline substitution in the MPR. Both basal and PMA-induced cleavage sites are identical, or at least very close (within 1-2 amino acids), and both processes are blocked by the metalloprotease inhibitor Ro 31-9790. Thus, these two enzymes would likely be closely related metalloproteases. There are many precedents for the shedding of a protein being mediated by more than one secretase. Furthermore, in cells in which TACE has been inactivated, there remains residual TNF-␣ shedding activity at a level of about 10% of normal, although, unlike basal L-selectin shedding, this residual cleavage is not blocked by metalloprotease inhibitors (23) . The membrane metalloprotease ADAM10 can cleave synthetic TNF-␣ peptide substrates and recombinant proTNF-␣ in vitro (81, 82) , and mediates shedding when overexpressed in intact cells (81) , but it does not compensate for the TACE-mediated shedding in TACEdeficient cells (3, 23) . In addition, there is evidence that an enzyme in addition to TACE, perhaps ADAM10, is responsible for some of the constitutive ␣-cleavage of APP (79, 83) . The shedding of another TNF family member, TRANCE, is mediated by at least two metalloproteases other than TACE (32) . Recent evidence has also suggested that while TACE is primarily responsible for shedding of the IL-6R, a separate metalloprotease mediates the basal cleavage of this receptor (29) . Thus, there is precedence for separate enzymes mediating shedding in activated and quiescent cells.
In summary, we have shown that murine L-selectin undergoes both constitutive proteolytic turnover in quiescent cells and accelerated shedding in activated cells. The basal shedding of this molecule appears to have the most relaxed structural requirements, being insensitive to mutations around the cleavage site, and requires only that the juxtamembrane domain be of sufficient length. In contrast, the rapid, induced cleavage of L-selectin is blocked by proline substitutions in its membraneproximal region, and it requires additional interaction with TACE mediated by the more NH 2 -terminal EGF domain. For ectoproteins in which protease recognition of a region separate from the cleavage domain is important, blocking such a site could provide a potential target for the therapeutic inhibition of shedding in pathological processes.
